Colorectal Cancer Treatment Market Share

Geographically, the colorectal cancer treatment market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. The market in the Asia Pacific industry is set to dominate majority revenue share by 2036, owing to increasing awareness about colorectal cancer and need to develop innovative cancer treatment solutions in the region.

Furthermore, in 2021, the market in North America is evaluated to occupy the largest share in terms of revenue, owing to the high prevalence of colorectal cancer, accompanied by the presence of leading healthcare service providers in the region. Along with this, North America also has an increasingly ageing population, which is also expected to contribute to the market growth in the region. Alternatively, the market in Europe is also anticipated to occupy a significant share in the market on account of the rise in colorectal cancer diagnostic tests and a large presence of individuals suffering from colorectal cancer in the region. As per an epidemiologic study from the European Union, in 2018, colorectal cancer was ranked second among the deaths from cancer in Europe, with 98000 deaths in men and 79,400 deaths in women.